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Abstract
Addictive disorders are a severe health concern. Conventional therapies have just moderate success and the
probability of relapse after treatment remains high. Brain stimulation techniques, such as transcranial Direct Current
Stimulation (tDCS) and Deep Brain Stimulation (DBS), have been shown to be effective in reducing subjectively
rated substance craving. However, there are few objective and measurable parameters that reflect neural
mechanisms of addictive disorders and relapse. Key electrophysiological features that characterize substance related
changes in neural processing are Event-Related Potentials (ERP). These high temporal resolution measurements of
brain activity are able to identify neurocognitive correlates of addictive behaviours. Moreover, ERP have shown
utility as biomarkers to predict treatment outcome and relapse probability. A future direction for the treatment of
addiction might include neural interfaces able to detect addiction-related neurophysiological parameters and
deploy neuromodulation adapted to the identified pathological features in a closed-loop fashion. Such systems
may go beyond electrical recording and stimulation to employ sensing and neuromodulation in the
pharmacological domain as well as advanced signal analysis and machine learning algorithms. In this review, we
describe the state-of-the-art in the treatment of addictive disorders with electrical brain stimulation and its effect on
addiction-related neurophysiological markers. We discuss advanced signal processing approaches and multi-modal
neural interfaces as building blocks in future bioelectronics systems for treatment of addictive disorders.
Keywords: Transcranial direct current stimulation, tDCS, Deep brain stimulation, DBS, Flexible electronics,
Multimodal neural interfaces, Closed-loop systems, Addiction, Substance use disorders, Neurotransmitters, Neural
activity, Event-related potentials, ERP
Background
Addictive disorders represent a severe health issue and a
high economic burden on society. About 31 Million
people suffer from substance use disorders (SUD) world-
wide (Institute for Health Metrics and Evaluation 2018).
The duration of hospitalisation for addiction is on the
order of several months exceeding costs of about $740
billion alone in the USA for health treatment, lost work
productivity and drug-related crime (National Institute
on Drug Abuse 2017). For the two most frequently con-
sumed substances, nicotine and alcohol, the probability
of relapse within the first year after treatment reaches
80–95% (Hendershot et al. 2011) revealing a lack of
efficacy of conventional behavioural and pharmaceutical
therapies.
So called “craving”, described as a strong desire or
compulsion to consume a substance in a state of with-
drawal (World Health Organisation (WHO) 2019), is the
core feature underlying SUD (Sayette 2016; Tiffany and
Wray 2012). Assessment of craving in humans is usually
performed using questionnaires which consist of self-
ratings on statements reflecting urges, desires and intent
of substance consumption, anticipation of positive/nega-
tive outcome and relief from withdrawal as well as lack
of control of substance consumption (e.g. Alcohol Crav-
ing Questionnaire (ACQ) (Singleton et al. 1994), Mari-
huana Craving Questionnaire (MCQ) (Heishman et al.
2001), Questionnaire on Smoking Urges (QSU) (Tiffany
and Drobes 1991)). However, these assessments have
been exposed to criticism as there is neither a consistent
definition of craving nor a conclusive opinion about its
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validity to understand addictive behaviour and relapse
(Perkins 2009; Wray et al. 2013). Nevertheless, its inclu-
sion in the International Classification of Diseases (ICD-
10, WHO 2004) and the Diagnostic and Statistical Man-
ual of Mental Disorders (DSM-5, Hasin et al. 2013), em-
phasises the value of craving to predict relapse and the
need to define objective parameters for its evaluation
(Sayette 2016).
Craving is particularly triggered by cues related to the
substance (e.g. the sound of opening a beer bottle or the
smell of a cigarette). In addicted individuals two pro-
cesses are thought to consequently provoke relapse: 1.)
attentional biases toward the drug-related stimulus that
induces the urge to consume the drug and 2.) impaired
inhibition to withstand the temptation by the drug-cue
(Campanella 2016) (Fig. 1, top).
In the following review we describe neurobiological
and electrophysiological parameters associated with
craving behaviour in SUD. We present studies that
applied brain stimulation techniques to modify these
parameters within clinical treatment of addiction (Table 1).
Finally, we outline the potential of intelligent bioelectronic
devices in individually adapted therapeutic approaches
based on neurophysiological correlates of SUD.
Correlates (biomarkers) of addiction
Neurobiology
In brain imaging studies an increased activation follow-
ing drug-related cues has been observed in neuronal
structures involved in attention, reward perception, ac-
tion selection, decision making and behaviour control
(George and Koob 2010), such as the dorsolateral pre-
frontal cortex (DLPFC), ventral striatum (VS), amygdala,
orbitofrontal cortex (OFC) and anterior cingulate cortex
(ACC) (Chase et al. 2011; Hayashi et al. 2013; Kühn and
Gallinat 2011). Furthermore, craving is associated with
changes in neurotransmitter contents within these areas
as revealed by measurements using implanted biosensors
in rodent models that received drug injections, self-
administered drugs via lever pressing or showed drug-
induced conditioned place preference (D’Souza 2015;
Lenoir and Kiyatkin 2013; Malvaez et al. 2015; Rahman
Fig. 1 Application of neuroprosthetic devices in SUD. Drug-related stimuli can induce craving and subsequent relapse in drug addicted
individuals such as a glass of beer in alcoholics. The loss of inhibitory control leading to alcohol consumption is accompanied by abnormally
decreased ERP amplitudes like for N2 and P3. Neuroprosthetic systems could identify and normalise these pathological features through different
brain stimulation methods leading to improved behaviour control and decreased relapse risk
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Table 1 Summary of studies investigating the effects of brain stimulation on electrophysiological correlates of addiction




Alcohol human Nacc Flanker task ERN↑ during 1 year of DBS
Ross et al.
(2016)




DBS vs. sham: decreased proportion of responsive neurons to
reward-related food at both frequencies






human 20 min, 2 mA, 35 cm2, 1x
left cathodal/right anodal vs. sham stim over DLPFC/ACC
Go/NoGo task with visual
drug-related vs. neutral
cues





human 20 min, 2 mA, 35 cm2, 1x per day over 5 days, left cathodal/right
anodal vs. sham stim over DLPFC




tDCS vs. sham: P3↑ after neutral, P3↓ after drug-related cues in
DLPFC
5th day
tDCS vs. sham: P3↑ after neutral and drug-related cues in
DLPFC, P3↑ after drug-related cues vs. P3↓ after neutral cues in
FPC, OFC, ACC
da Silva et al.
(2013)
Alcohol human 20 min, 2 mA, 35 cm2, 1x per week over 5 weeks
anodal vs. sham stim over left DLPFC
Go/NoGo task with visual
drug-related vs. neutral
cues
N2↑ sham & tDCS, neutral and drug-related cues
P3↑ sham, neutral cues
P3↓ sham & tDCS, drug-related cues
Density of activation ↓ after tDCS vs. sham in FPC, OFC, ACC,
DLPFC
den Uyl et al.
(2016)
Alcohol human 15 min, 1 mA, 35 cm2, 1x per day over 3 days
anodal over left DLPFC/cathodal over right supraorbital area vs.
sham stim
Alcohol oddball task with
visual drug-related vs. neu-
tral cues




Alcohol human 10 min, 1 mA, 35 cm2, 1x
anodal over left DLPFC/cathodal over right supradeltoid area
vs. sham stim
passive listening to auditory
drug-related vs. neutral
cues







human 20 min (Crack-users) or 2 × 13 min (Alcoholics), 2 mA, 35 cm2, 1x
per day over 5 days, left cathodal/right anodal vs. sham stim
over DLPFC
Go/NoGo task with visual
drug-related vs. neutral
cues
Density of P3 activation ↑ after tDCS vs. sham after drug-
related cues predominantly in vmPFC
Lapenta et al.
(2014)
Food human 20 min, 2 mA, 35 cm2, 1x
left cathodal/right anodal vs. sham stim over DLPFC
Go/NoGo task with visual
food-related vs. neutral cues








































et al. 2005; Scofield et al. 2015; Wakabayashi and Kiyat-
kin 2012).
Dopamine, which is involved in various cognitive pro-
cesses like decision making and action planning, plays a
key role in the reinforcement of actions associated with
reward and positive feelings. Repetitive drug consump-
tion increases the activity of dopaminergic neurons ele-
vating dopamine concentration in the ACC, amygdala
and nucleus accumbens (NAcc) (Vollstädt-Klein et al.
2012; Ward et al. 2009). Particularly, in the NAcc, ven-
tral tegmental area (VTA) and prefrontal cortex (PFC),
dopamine is also co-released with glutamate, an excita-
tory neurotransmitter influencing impulsive behaviour
and attentional, motivational and emotional processes in
the context of drug-related stimuli. Drugs affect the glu-
tamate metabolism in different ways: while cocaine in-
take activates dopamine D1 receptors that subsequently
increase excitatory glutamate transmission, heroin and
alcohol do so by reducing GABAergic interneuron inhib-
ition on presynaptic glutamate transmission (D’Souza
2015; Lüscher and Malenka 2011).
Also increased levels of serotonin, a regulator of emo-
tions, stress and appetite, are induced by various drugs
such as alcohol, cocaine and methamphetamine. A sub-
sequent dysregulation of the serotonin metabolism is as-
sociated with anhedonia, dysphoria, depression and
anxiety during abstinence and consequently triggers
drug seeking (Belmer et al. 2016; Müller et al. 2010;
Ward et al. 2009).
Electrophysiology
Electroencephalography (EEG) is a non-invasive, pain-
less, low cost and easy-to use-method to record elec-
trical brain activity with a high temporal resolution.
While resting state-EEG records mainly spontaneous
neural activity, indicating a rather fundamental brain
state (Bai et al. 2017), Event-Related Potentials (ERP) are
induced by a stimulus representing associated sensory,
cognitive, affective and motor processes (Kappenman
and Luck 2011).
ERP are commonly defined as time-locked local posi-
tive or negative maxima within voltage waveforms re-
corded during EEG that arise from postsynaptic
potentials (PSP) of a large amount of spatially aligned
cortical pyramidal neurons. PSP are based on neuro-
transmitter bindings to the postsynaptic cell membrane
causing opening/closing of ion channels and subsequent
alterations in electrical potentials. ERP-related voltage
changes are on the order of a few microvolts (μV) lasting
tens to hundreds of milliseconds (msec). They are com-
monly named according to their polarity (positive = P,
negative = N) and latency (either in milliseconds or as
their order of appearance within the recorded waveform)
(Kappenman and Luck 2011).
Studies to investigate ERP in the context of SUD in-
volve visual or auditory substance-related stimuli pre-
sented commonly in inhibitory control paradigms such
as oddball, Go/NoGo, Stroop or Flanker tasks (Moeller
and Paulus 2018). ERP discussed in the context of SUD
include the components N170, N2/mismatch negativity
(MMN), N400, P50, N1/P2, P3, the late positive poten-
tial (LPP) and the error-related negativity (ERN) and are
now described in more detail.
N170
The N170 component occurs between 130 and 200 msec
after stimulus onset with largest amplitudes at occipito-
temporal electrode sites. It has been shown to be most
pronounced when images of faces or eyes were used as
stimuli (Earp and Everett 2013). With regard to SUD,
prolonged latencies and decreased amplitudes of the
N170 component were detected in alcoholic individuals
vs. controls in response to face images with varying
emotional expressions (Maurage et al. 2007, 2008) and
in multiple substance-addicted mothers when con-
fronted with pictures of infant faces (Landi et al. 2011).
These results might indicate altered visual or emotional
processing in SUD and a diminished neural reaction to
reward (Rutherford et al. 2013). In response to
substance-related cues, alcohol-addicted individuals dis-
played larger NoGo N170 amplitudes and a higher rate
of relapse in a 3-month follow-up assessment compared
to abstinent patients suggesting that the N170 might be
useful in evaluating substance-related visual cue sensiti-
vity and treatment success (Matheus-Roth et al. 2016).
N2
The N2 component occurs mainly at frontal electrode
sites approximately 100–350 msec after stimulus onset
and reflects an automatic response to changes in stimu-
lus properties (Sur and Sinha 2009). Its subcomponent
N2a or MMN peaks approximately 150 msec post-
stimulus and is usually induced by a deviant auditory
cue in a series of frequent, similar sounds (Campanella
et al. 2014).
In alcohol addicts vs. controls, reduced N2 amplitudes
for Go as well as NoGo task conditions (Pandey et al.
2012) and even absence of the N2 component were ob-
served in heavy drinkers, while higher N2 amplitudes for
NoGo trials compared to Go trials for alcohol-related cues
were detected in study participants with a high level of al-
cohol avoidance (Kreusch et al. 2014). A reduced N2 in
NoGo task conditions has also been observed in tobacco
smokers (Buzzell et al. 2014), cannabis users (Nicholls
et al. 2015), and, besides a prolonged latency, also in her-
oin addicts (Motlagh et al. 2016, 2017), while consumers
of methylenedioxymethamphetamine (Ecstasy, MDMA)
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displayed increased N2 amplitudes in a semantic retrieval
task (Roberts et al. 2013).
Longer latencies and increased N2 amplitudes in a vis-
ual distractor task have also been observed in multiple
substance-addicts, that discontinued treatment early
when compared to those participants that continued
treatment (Fink et al. 2016). Such data clearly illustrate
the value of the MMN as a sensitive marker of impaired
cognitive control and treatment success (Buzzell et al.
2014).
N400
The N400 is observed between 200 and 600 msec after
stimulus onset predominantly at centro-parietal sites. As
the N400 mostly occurs following visual or auditory
meaningful words, it has been associated with language
comprehension, semantic information processing and
semantic memory (Kutas and Federmeier 2011). The
N400 has been primarily studied in schizophrenia and
correlates with deficits in interpreting associations be-
tween objects or events that underlie unusual thoughts
and delusions (Jacob et al. 2019; Kiang and Gerritsen
2019). But also in the context of SUD, reduced amplitudes
and increased latencies of the N400 component have been
observed in alcohol addicts (Ceballos et al. 2005) and their
offspring (Roopesh et al. 2009) as well as frequent
cannabis consumers (Kiang et al. 2013), who additionally
displayed a disturbed semantic comprehension.
P50
The P50 component peaks between 40 and 75 msec after
an auditory stimulus mainly at central electrode sites.
After the second of two identical sounds (“paired click”
paradigm) it appears with a reduced amplitude reflecting
an inhibited response to repetitive stimuli (Campanella
et al. 2014; Sur and Sinha 2009). The P50 sensory gating
works as a preattentional inhibitory filter mechanism en-
abling attention to salient stimuli while ignoring redun-
dant or trivial information (Lijffijt et al. 2009; Sur and
Sinha 2009). A pronounced P50 sensory gating effect
has been associated with better task performance and
faster reaction times and is supposed to reflect an
individual’s ability to control attention and inhibition of
conflicting information input (Lijffijt et al. 2009).
Deficits in P50 suppression have been observed in a
variety of psychiatric diseases including SUD. Reduced
P50 difference scores relative to controls in the paired-
click paradigm have been detected in alcoholic individ-
uals (Marco et al. 2005; Sklar and Nixon 2014), tobacco
smokers (Brinkmeyer et al. 2011; Knott et al. 2010a,
2010b), cannabis consumers (Broyd et al. 2013, 2016),
cocaine addicts (Boutros et al. 1993; Boutros et al. 2002;
Fein et al. 1996) and in those under the influence of
acute amphetamine application (Light et al. 1999),
suggesting it is a marker of substance-related impaired
early sensory processing.
N1/P2
The P2 occurs between 150 and 250 msec after a visual
or auditory stimulus at fronto-central areas. Together
with the N1 component, that peaks 80–150 ms post-
stimulus at centro-temporal (auditory) or occipital (vis-
ual) areas, the P2 is also involved in sensory gating but
supposedly underlies different cognitive mechanisms
than the P50 related to triggering and allocation of at-
tention (Lijffijt et al. 2009). Here, increased amplitudes
of N1 and decreased amplitudes of P2 reflect the case of
consciously attending to a stimulus (Crowley and Col-
rain 2004). Deficits of N1/P2 sensory gating revealed by
decreased amplitudes of both components have been ob-
served in cocaine addicts vs. controls with additionally
prolonged latencies with comorbid paranoia (Boutros
et al. 2006), suggesting that the N1/P2 complex corre-
lates with perceptual aberrations (Gooding et al. 2013).
Using a visual two-alternative forced choice task,
decreased P2 amplitudes have also been detected in
frequent MDMA consumers (Casco et al. 2005). Dimin-
ished auditory N1/P2 amplitudes were further detected
in former and current tobacco smokers vs. never-
smokers correlating with years and amount of daily
consumed cigarettes (Jawinski et al. 2016).
In patients undergoing methadone maintenance treat-
ment for opiate addiction, Wang et al. (2015) detected
increased P2 amplitudes compared to healthy controls in
reaction to target stimuli in an auditory oddball task
suggestive of chronically altered sensory information
processing following prolonged opiate consumption.
P3
The P3 is a large, long-lasting component observed
between 300 and 700msec at central-parietal sites after
onset of visual or auditory stimuli. Its amplitude varies in
dependence of frequency and significance of the stimulus
and motivation and vigilance of the subject. The P3 has
been associated with a wide range of attentional, memory
and premotor decisional processes including activation of
inhibitory mechanisms (Campanella et al. 2014). A reduc-
tion in the P3 amplitude in common oddball tasks has
been shown to be a potential indicator of impaired inhibi-
tory processes and has been suggested an endophenotype
for externalizing psychopathology that should conse-
quently be used for its diagnosis and treatment (Brennan
and Baskin-Sommers 2018; Campanella 2013).
In numerous studies with alcohol use disorder (AUD)
patients, ERP following alcohol-related visual or auditory
stimuli displayed reduced amplitudes and increased la-
tencies of the P3 component compared to control sub-
jects (Cohen et al. 2002; Kathmann et al. 1996; Kreusch
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et al. 2014; Maurage et al. 2008). This has been associ-
ated with an impaired behaviour control and a higher re-
lapse probability (Iacono et al. 2002; Polich 2007).
Similar findings were reported for animal models of al-
cohol addiction (Criado and Ehlers 2009; Ehlers et al.
2014; Slawecki et al. 2003). The P3 component is there-
fore considered the best predictor and biomarker for the
relapse risk after alcohol withdrawal (Petit et al. 2015).
In addition, the P3 has been suggested as a potential
marker for vulnerability to develop AUD. In alcohol
naïve, young adult offspring of families with a history of
AUD, altered P3 patterns with higher amplitudes com-
pared to controls were identified. Furthermore, P3 am-
plitudes were equally high in Go and NoGo conditions.
This leads to the assumption that similar effort might be
necessary to distinguish between Go and NoGo and to
inhibit behaviour in the NoGo condition (Domínguez-
Centeno et al. 2018).
Similarly, a number of studies in tobacco smokers vs.
non-smokers reported increased P3 amplitudes to
smoking-related visual cues and decreased NoGo P3 am-
plitudes in Go/NoGo tasks as an indicator for condi-
tioned learning, craving, impaired behaviour control and
increased relapse risk (Littel and Franken 2012; Luijten
et al. 2016; Mashhoon et al. 2018; Piasecki et al. 2017;
Yin et al. 2016).
In cannabis users vs. controls, P3 amplitudes were re-
duced in a dose-dependent manner in a visual selective
attention task (Böcker et al. 2010) and an auditory odd-
ball task (D’Souza et al. 2012). Remarkably, the reduc-
tion in amplitudes persisted hours after consumption.
The P3 component has also been shown to display de-
terioration of clinical symptoms by cannabis consumption:
cannabis-induced alterations in emotion processing, re-
vealed by decreased P3 amplitudes during an emotional ex-
pression recognition task, were present in depressive
patients and healthy controls but more pronounced in diag-
nosed depression (Troup et al. 2017). In psychotic patients
cannabis-induced decreases in auditory P3 correlated with
severity of psychopathology (van Tricht et al. 2013).
Disturbed cognitive processing related to psychosis
as indicated by the P3 has further been investigated
in the context of psychedelic drugs. Application of
psilocybin to healthy subjects induced psychotic-like
symptoms and a disrupted auditory P3 that decreased
with increasing intensity of the psychedelic status
(Bravermanová et al. 2018). In previous moderate and
heavy MDMA consumers, reduced P3 amplitudes in a
visual discrimination task even 6 months after last
drug intake indicate long lasting impairments in cog-
nitive performance (Casco et al. 2005). Decreased
midline NoGo P3 amplitudes in a Go/NoGo task fur-
ther point to disturbed inhibitory brain mechanisms
in MDMA consumers (Gamma et al. 2005).
Effects of heroin on P3 are inconsistent. A reduced P3
amplitude in heroin users compared to controls was ob-
served during an auditory oddball task (Marques-Teix-
eira and Barbosa 2005; Motlagh et al. 2017) and short
memory task (Papageorgiou et al. 2004), while others did
not detect differences (Wang et al. 2015; Yang et al.
2009) or report increased P3 amplitudes during a visual
oddball task with heroin-related stimuli (Lubman et al.
2007; 2008).
Cocaine addicted individuals displayed reduced P3 am-
plitudes to visual (Conti et al. 2015) and auditory (Moeller
et al. 2004) drug cues. Furthermore, the P3 component
has been shown to be a suitable marker to predict relapse
also in former cocaine consumers (Bauer 1997).
In methamphetamine consumers, increased P3 ampli-
tudes to drug-related pictures (Shahmohammadi et al.
2016) and words (Haifeng et al. 2015) have been
detected at the beginning of a therapy. With increasing
duration of abstinence, P3 amplitudes normalised
suggesting treatment success.
LPP
The Late Positive Potential (LPP) is a slow wave occur-
ring 400–800 msec after presentation of visual stimuli at
fronto-central sites. It is elicited by both, pleasant and
unpleasant, emotionally salient stimuli and is therefore
associated with emotional arousal (Gibney et al. 2019).
Increased LPP amplitudes and high craving scores to
drug-related stimuli have been observed in cocaine-
addicts suggesting that the LPP reflects stimulus ap-
proaching behaviour (Franken et al. 2008). These effects
can be effectively reversed by prolonged duration of ab-
stinence as shown in a 6-month follow up assessment.
Therefore, the LPP might serve as a cocaine-related
attention bias in addicted individuals and an indicator
for treatment success (Parvaz et al. 2017).
In a study with tobacco smokers vs. non-smokers,
smoking-related pictures induced increased LPP ampli-
tudes in both groups (Deweese et al. 2018) pointing to the
fact that positive and negative feelings towards the stimu-
lus influence the LPP. Nevertheless, health warning stim-
uli on cigarette packages resulted in reduced and delayed
LPP in smokers vs. non-smokers (Stothart et al. 2016).
ERN
The error-related negativity (ERN) is a negative,
stimulus-independent component originating from the
ACC and observed at fronto-central areas approx. 60–
110 msec after a subject realizes they relayed a wrong (or
missing) response. The ERN is considered to be a moni-
toring system for error detection to prevent uncontrolled,
undesirable actions (Wauthia and Rossignol 2016).
Normally, adolescents show increasing ERN with age.
In a longitudinal study using a Flanker task, adolescents,
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who consumed tobacco later in early adulthood, dis-
played reduced amplitudes at ages 14 and 16 and slower
developmental ERN changes suggesting that an impaired
error monitoring could predict development of addictive
behaviour (Anokhin and Golosheykin 2015). These find-
ings are further supported by studies with individuals
having a family history of SUD and are therefore at risk
also to develop an addiction: offspring of cannabis con-
sumers (Euser et al. 2013) and alcoholics have been
shown to display reduced ERN similar to already
addicted individuals, supporting the ERN as an indicator
of disease status (Gorka et al. 2019). Also in cocaine-
dependent patients vs. controls reduced ERN amplitudes
in a Flanker task have been shown to reliably predict re-
lapse within 3-month (Marhe et al. 2013).
Neuromodulation strategies for addictive
disorders
Deep brain stimulation
Deep Brain Stimulation (DBS) is delivered via invasive
electrodes implanted in specific brain areas. Such sys-
tems are fully implanted and additionally include a sub-
cutaneously placed pulse generator (Alonso et al. 2016).
DBS for SUD has been applied to a small number of se-
vere and otherwise treatment resistant cases. In AUD,
DBS of the NAcc has been shown to successfully de-
crease craving and enable long-term abstinence (Heinze
2009; Kuhn et al. 2011; Müller et al. 2016; Voges et al.
2013). NAcc-DBS has also been successfully applied in a
methamphetamine-addicted patient that remained ab-
stinent for the 2-year follow up period (Ge et al. 2019).
Application of simultaneous DBS of the NAcc and an-
terior limb of the internal capsule (ALIC) in heroin ad-
dicts resulted in decreased craving and abstinence in 5
out of 8 patients (Chen et al. 2019).
Further support for NAcc-DBS comes from rodent
studies, where it has been shown to effectively reduce
seeking for cocaine (Guercio et al. 2015; Hamilton et al.
2015), methamphetamine (Batra et al. 2017) and sucrose
(Guercio et al. 2015) suggesting that NAcc-DBS dimin-
ishes general reward seeking behaviour.
So far, investigations on effects of DBS on ERP have
been restricted to patients receiving DBS as treatment
for Parkinson’s disease (PD), obsessive compulsive disor-
ders (OCD) or treatment resistant depression. Thereby,
DBS has widely been applied to the subthalamic nucleus
(STN) that is involved in motor performance and also
non-motor functions such as behaviour inhibition and
error monitoring. Recordings of visual ERP in PD pa-
tients with vs. without bilateral DBS of the STN induced
a stimulation intensity-dependent decrease of amplitudes
of N70 and P1 (Jech et al. 2006). In a visual working
memory task, STN-DBS furthermore reduced N2 ampli-
tudes while increasing its latencies (Selzler et al. 2013).
Using standard auditory oddball paradigms, no signifi-
cant changes have been detected in amplitudes of N1,
N2, P2 and P3 in PD patients when STN-DBS was
switched on vs. off (Kovacs et al. 2008; Naskar et al.
2010). However, Kovacs et al. (2008) found a positive
correlation between fronto-central P3 amplitudes and
optimal stimulation voltage and between P3 latencies
and duration of the disease. Furthermore, increased N1
latency towards the target tone was observed when DBS
was turned on (Naskar et al. 2010). Gulberti et al. (2015)
could restore deficits of auditory sensory gating in PD
patients by normalizing abnormally increased N1/P1
amplitudes and N1 latencies by chronic STN-DBS.
OCD patients receiving bilateral STN-DBS displayed a
reduced amplitude and increased latency of the P3 com-
ponent in conjunction with faster reaction times during
a stop-signal task when stimulation was switched on
(Kibleur et al. 2016).
Kibleur et al. (2017) applied DBS to the subgenual cin-
gulate gyrus (CG25) in patients suffering from treatment
resistant depression and analysed its effect on emotional
processing in a Stroop task showing pictures of faces.
DBS significantly reduced overall N170 amplitudes and
influenced emotional valence as revealed by larger N170
amplitudes in emotional vs. neutral control conditions.
In addition, increased P3 amplitudes were observed in
neutral vs. emotional trials. In a long-term study with
depressive patients treated with DBS of the subcallosal
cingulate (SCC), Hilimire et al. (2015) detected signifi-
cantly decreased P1 and P3 amplitudes for negative
words in an emotional self-referential task. This suggests
that SCC-DBS changes automatic attentional focusing
and controlled processing of negative information.
Beneficial effects of DBS on impaired auditory informa-
tion processing and sensory gating have also been shown
in a rat model of schizophrenia. By applying bilateral DBS
to the ventral hippocampus, deficits of auditory P50 and
N1 in the thalamic mediodorsal nucleus (MD) and infra-
limbic cortex were reversed (Ewing and Grace 2013).
Electrocorticography & direct electrical stimulation
Electrocorticographic (ECoG) recordings and direct elec-
trical stimulation (DES) of the cortex are performed with
epi- or subdural electrode arrays placed on the surface
of the brain. As they are not penetrating brain tissue like
DBS electrodes, ECoG arrays are associated with a lower
risk for side effects and a greater long-term stability
(Leuthardt et al. 2006).
ECoG applications are mainly used in patients suffer-
ing from medically intractable epilepsy to localize seizure
foci prior to surgical intervention (Fernández and Lod-
denkemper 2013) and for real-time functional brain
mapping to assess language, motor performance and
sensory function through application of DES via EcoG
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electrodes (Boyer et al. 2018; Caldwell et al. 2019;
Mouthaan et al. 2016).
When used for electrophysiological measurements,
ECoG–recorded ERP have been shown to correspond to
ERP measured with EEG (Krusienski and Shih 2010) and
might even been detected with potentially better accur-
acy as ECoG offers a higher spatial resolution, broader
bandwidth, higher signal sensitivity and less vulnerability
to artifacts compared to EEG (Leuthardt et al. 2006).
This is further indicated by the application of the so
called “P300 matrix speller”, an originally EEG-based
BCI system that uses ERP to enable severely disabled pa-
tients to communicate. Using ECoG signals instead of
EEG significantly improved and sped up spelling per-
formance (Brunner et al. 2011; Speier et al. 2013). Miller
et al. (2016) demonstrated that visual ERP and broad-
band changes recorded with subdural ECoG provide suf-
ficient information to enable near-instantaneous, highly
accurate identification of occurrence, timing, and cat-
egory of perceived objects.
To our knowledge, ECoG and/or DES have neither
been used for therapeutic applications nor for research
purposes related to addictive disorders so far but have
long been discussed in the context of brain computer in-
terfaces (Caldwell et al. 2019; Kapeller et al. 2014;
Leuthardt et al. 2006; Rembado et al. 2017; Schalk and
Leuthardt 2011) and therefore provide a basis for
medical closed-loop neuroprosthetics with a great poten-
tial also in treatment of addictive disorders.
Transcranial direct current stimulation
Transcranial Direct Current Stimulation (tDCS) is a
non-invasive, painless, inexpensive and easy-to-use brain
stimulation technique with minimal side effects (Bastani
and Jaberzadeh 2012). TDCS using weak electrical cur-
rents is based on a subthreshold mechanism not directly
inducing pre- or postsynaptic cell firing and rather mod-
ulates spontaneous neuronal activity (Stagg and Nitsche
2011). Cathodal stimulation induces a hyperpolarisation
of the resting membrane potential decreasing cortical
excitability, while anodal stimulation enhances it
through depolarisation of neuronal membranes (Antal
et al. 2009).
In the context of addictive disorders, tDCS has been
shown to successfully decrease craving scores in AUD
patients (den Uyl et al. 2015; Wietschorke et al. 2016),
cigarette smokers (Boggio et al. 2009), cannabis users
(Boggio et al. 2010), cocaine (Batista et al. 2015) and
heroin addicts (Wang et al. 2016) and methampheta-
mine users (Shahbabaie et al. 2014).
Several studies have been investigating the effects of
tDCS on neurophysiological parameters in healthy sub-
jects. Izzidien et al. (2016) found a significant increase in
P3 power after application of anodal stimulation over
the left motor cortex during a spelling task of an oddball
paradigm. Keeser et al. (2011) identified increased P2
and P3 amplitudes in a working memory n-back task
after anodal tDCS. Cathodal tDCS applied to the cere-
bellum, that supposedly interacts with cortical brain
areas in attentional processing, induced an amplitude re-
duction of N1, N2 and P3 components for target and
novel stimuli in a P3 novelty task (Mannarelli et al.
2016). Also, effects of tDCS on MMN were investigated
revealing increased MMN amplitudes after anodal tDCS
over the left auditory cortex and decreased sensory
discrimination following cathodal stimulation in an
auditory oddball paradigm (Impey et al. 2016).
Application of brain stimulation to modulate
electrophysiological correlates of addiction
There are numerous studies that investigated either ef-
fects of brain stimulation on subjectively rated craving,
drug seeking and consumption in humans (reviewed e.g.
in Coles et al. 2018; Luigjes et al. 2019; Salling and
Martinez 2016) and animals (reviewed e.g. in Wang
et al. 2018) or addressed electrophysiological correlates
of addiction (reviewed e.g. in Campanella et al. 2014;
Houston and Schlienz 2018; Luijten et al. 2014). Never-
theless, research on how brain stimulation modulates
neurophysiological biomarkers associated with addictive
behaviour remains sparse (Table 1). This is expected to
be important in a closed-loop neuromodulation system
where stimulation parameters will be adjusted in re-
sponse to a dynamically changing biomarker.
Due to its invasiveness DBS has not yet been widely ap-
plied for the treatment of SUD. Kuhn et al. (2011) report,
that after 1 year of NAcc-DBS treatment in an alcohol
addicted patient, an increased, normalised ERN in parallel
with decreased craving and alcohol consumption was ob-
served. They further speculate, that such positive effect of
DBS on addictive behaviour originates from an enhanced
cognitive control through improved ACC functioning.
In rats, Ross et al. (2016) examined effects of DBS of
the central nucleus of the amygdala (CeA) on the reward
circuitry that is dysregulated in addiction. During DBS,
animals stopped lever pressing for sucrose pellets and
rejected freely available food rewards. Taste reactivity
tests revealed aversive reactions to usually liked food
tastes under influence of DBS. Neural spike recordings
furthermore indicated a decreased response of CeA neu-
rons to reward-related stimuli showing that modulation
of CeA activity through DBS is able to diminish craving
for rewards. To our knowledge, there are no further
studies that examined the influence of DBS on
substance-related ERP abnormalities.
A few more studies applied tDCS to modify addiction-
related ERP changes. Conti, Nakamura-Palacios and col-
leagues (2014, 2016) used single and repeated bilateral
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tDCS in crack-cocaine addicts targeting the DLPFC and
ACC. ERP measurements before and after stimulation
revealed a significant reduction of the N2 over the ACC
and the P3 over the DLPFC for crack-related images
after a single tDCS session. Additionally, repeated tDCS
up to 5 days increased the P3 component for drug-
related cues over wider cortical areas, which correlated
with lesser relapses and therapy dropouts and might in-
dicate an improved behaviour control after repetitive
tDCS treatment (Conti and Nakamura-Palacios 2014;
Conti et al. 2014; Nakamura-Palacios et al. 2016).
In alcohol addicted individuals, repeated (two sessions)
tDCS induced an increased P3 for alcohol related pic-
tures with a dominant activation within the vmPFC
(Nakamura-Palacios et al. 2016) while den Uyl et al.
(2016) observed a slight reduction of the P3 component
for alcohol related images after 3 stimulation sessions
over the DLPFC, possibly indicating a reduced sensitivity
for alcohol related stimuli. Nakamura-Palacios et al.
(2012) detected an increased P3 amplitude for alcohol-
related sounds after a single bilateral tDCS session. This
was further accompanied with improved performance in
the Frontal Assessment Battery that involves evaluation
of executive functions, memory and calculation skills. As
frontal dysfunction is associated with deficiencies in in-
hibition, tDCS-induced frontal enhancement might
therefore contribute to improved behaviour control in
alcoholic individuals.
Craving also plays a role in addictive eating disorders.
Lapenta et al. (2014) observed a decreased N2 and en-
hanced P3 amplitude for visual NoGo stimuli after a sin-
gle bilateral tDCS session in obese patients. Additionally,
tDCS could reduce food consumption. This, further-
more, underlines the modulatory effects of tDCS on the
inhibitory control circuitry.
Taken together, the presented studies demonstrate a
measurable effect of tDCS on electrophysiological
markers of SUD. Markers of SUD have also been shown
to quantitatively correlate with the applied stimulation
parameters (number of sessions, duration, dosage) and
targeted brain area. The reported effects are so far re-
stricted to the N2 and P3 components in a small num-
ber of crack-cocaine and alcohol addicted individuals.
Therefore, research needs to be extended to further clar-
ify the influence of brain stimulation on ERP in the con-
text of substance-related disorders and to define optimal
stimulation settings. For DBS the limited availability of
data does not yet allow a conclusion about its influence
on neurophysiological markers in SUD.
Future directions: intelligent closed loop systems
The existing non-invasive brain stimulation studies for
addictive disorders have been mainly delivered in an
“open-loop”, “one-size-fits-all” fashion. In other words,
the stimulation parameters (e.g. intensity, frequency,
timing and target site of the stimulation) are the same
for all the participants and do not vary over the time
with changes in the current brain states. However, many
factors including differences in brain anatomical features
across participants, heterogeneity of addictive disorders
and considerable changes in brain-states over time
would suggest that using brain stimulation in an “open-
loop”, “one-size-fits-all” fashion could not be optimum
and might be the main reason for the observed large in-
ter- and intra-individual variability in the response to
brain stimulations (Li et al. 2015).
The effectiveness of brain stimulation in addictive dis-
orders can be further enhanced by providing individua-
lised closed-loop brain stimulation, where the
parameters of stimulation (e.g. precise target site and in-
tensity of stimulation) are defined for each individual
separately and adjusted over the time based on consecu-
tive and concurrent recordings of brain activity (Zrenner
et al. 2016). For example, a pre-defined parameter (e.g.
neural activity in the form of ERP) can be constantly
monitored and adjusted to a desired target value. This
would mean that a stimulation is applied only when an
abnormal neural activity specific for a given disease (e.g.
modified ERP-amplitudes and latencies in addicted indi-
viduals when confronted with drug-associated cues) is
measured (Fig. 1).
Electrophysiological signals recorded immediately be-
fore starting the brain stimulation can be used to iden-
tify relatively stable spatial information that have large
inter-subject but small intra-subject variability. For ex-
ample, through spatial localization of certain ERP com-
ponents and relevant oscillations, the precise target site
and optimal position of the stimulation can be calculated
for each individual using advanced high-density EEG
source localization and connectivity techniques
(Bergmann et al. 2016).
Recent advances in the development of machine
learning algorithms in the context of EEG-based brain
machine interfaces used e.g. logistic regression, Bayes
estimation, support vector machines (Abibullaev and
Zollanvari 2019), convolutional or recurrent neural
networks (Lawhern et al. 2018; Roy et al. 2019) to
identify specific electrophysiological neural features
in real-time using continuously recorded neural ac-
tivity. Brain potentials thereby classified as “patho-
logical” could be used to adjust stimulation to
normalise neural activity and improve behaviour
control enabling an individually and situationally
adapted intervention (Campanella 2013). Further-
more, this would reduce side effects observed in
continuous stimulation like impaired speech, gait
disorders and cognitive deficits induced by DBS
(Buhmann et al. 2017).
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To have a successful intelligent closed-loop brain
stimulation for addictive disorders, the following meth-
odological challenges need to be carefully addressed.
The identified neural features need to be sufficiently ro-
bust against noise and artifacts in order to be reliably
monitored in real-time (Arvaneh and Tanaka 2018;
Kaplan et al. 2005). Moreover, the analysis pipeline
needs to be sufficiently fast. Generally, the high temporal
resolution provided by EEG should allow a real-time
closed loop brain stimulation approach. However, the
EEG is known to have a low spatial resolution (Hu et al.
2011). Thus, averaging across multiple trials might be
necessary to make a reliable decision about changes of a
specific EEG component. However, this might yield a
delay in a closed loop system and reduces its effective-
ness. Advanced machine learning algorithms and spatial
filters are necessary to increase the spatial resolution of
EEG signals, leading to reliable closed loop brain stimu-
lations. Depending on the site of the stimulation, an-
other challenge in the design of a successful closed-loop
brain stimulation could be the brain stimulation-related
artifacts in EEG (Helfrich et al. 2014). Removing these
artifacts require advanced spatial filtering and template
subtraction techniques (Marshall et al. 2016; Helfrich
et al. 2014).
Future directions: multimodal neural systems for
addiction therapy
The realisation of neuroprosthetic systems for treating
addictive disorders will depend on reliable monitoring of
biomarkers and delivery of neuromodulation. This may
be achieved using invasively implanted probes which
offer advantages in terms of spatial and temporal select-
ivity. Electrode arrays have for some time formed the
basis of clinical systems for delivering tonic stimulation
to basal ganglia or for recording neural activity from the
cortical surface (Coffey 2009; Cook et al. 2013). As the
nervous system is also a chemical and thermal machine,
recording and neuromodulation do not need to be re-
stricted to the electrical domain only. A multi-modal ap-
proach may enable exploration of synergistic effects
(decrease of stimulation/inhibition thresholds), decoup-
ling of stimulation and recording (reducing artifacts in
feedback sensor signals), side effect management or con-
trol of function in specific neural circuits (Frank et al.
2019; Kleinbart et al. 2018; Minev et al. 2015). These
potential benefits are still not exploited in clinical
devices but reports of hybrid interfaces are growing in
the pre-clinical literature.
Neurotransmitter sensing can be facilitated by elec-
trode arrays. These are similar to recording electrodes
but sensing is enabled by electrochemical methods such
as fast scan cyclic voltammetry (FSCV) or amperometry
(Demuru et al. 2018). These are often made from carbon
which is inert in the potential window used for sensing.
In the case of dopamine sensing, FSCV is used to cata-
lyse and detect a red-ox reaction that is specific to dopa-
mine and occurs at low electrode potentials. Ashouri
Vajari et al. (2018) have reported on the fabrication of a
DBS probe for simultaneous sensing of dopamine com-
bined with simulating electrodes. For species that are
not electroactive (e.g. glutamate), the sensing electrode
can be coated with a selective membrane and an enzyme
(e.g. glutamate oxidase) that converts the neurotransmit-
ter to an electroactive species (e.g. H2O2) that can be
detected electrochemically (Ganesana et al. 2019). An
example of an integrated sensing system for detection of
dopamine, glutamate and adenosine is the wireless in-
stantaneous neurotransmitter concentration sensing sys-
tem (WINCS) which may be used as the sensing arm in
closed loop or adaptive DBS (Van Gompel et al. 2010).
Electrochemical methods of neurotransmitter detection
have some advantages over more traditional microdialy-
sis probes (Rogers et al. 2017) because of their smaller
footprint, response speed on the order of seconds and
because their fabrication shares many steps with that of
traditional electrode arrays (Ou et al. 2019). Application
of advanced fabrication strategies such as multi-fiber
braiding and 3D printing open further possibilities for
parallel detection from multiple sites and for engineering
the mechanical properties of probes closer to that of soft
brain tissues (Wang et al. 2019;Yang et al. 2018).
Probes that sense biopotentials in the electrical do-
main and deliver modulation via drugs have also
attracted interest. Microfluidic chips integrated with
electrodes have been used to mix and deliver up to three
drugs to mouse brains and have demonstrated parallel
electrical recording (Shin et al. 2015). Microfluidic con-
duits integrated within penetrating fiber probes have
been used to deliver viral vectors for in situ optogenetic
transfection. These probes also had electrodes and
optrodes running parallel to the long axis of the fiber
which were used to stimulate and record cells in the
vicinity of the probe tip (Park et al. 2017). Minev et al.
(2015) demonstrated the synergistic effect of electrical
and pharmacological stimulation of the spinal cord from
a surface probe, which in rats sustaining spinal cord in-
jury was used to restore locomotion. One consideration
for the deployment of microfluidics (volume flow) sys-
tems is maintaining patency of the channel in a chronic-
ally implanted setting. Disruption of the blood brain
barrier, adsorption of proteins on polymer surfaces, and
micromotions can lead to activation of a foreign body
reaction that may interfere with the patency of the deli-
very system (Del Bigio 1998). Another solution may be
to deliver the active molecule through a selective mem-
brane using electrophoresis. This approach has the bene-
fit of not requiring the transfer of large volumes of
Habelt et al. Bioelectronic Medicine             (2020) 6:4 Page 10 of 17
solvent to the brain and the maintenance of a patent chan-
nel. An example of this approach is a miniaturised ion
pump. This has been demonstrated for the delivery of
GABA, K+ and glutamate in rodent animal models for
localised chemical neuromodulation in the brain spinal
cord and cochlea (Jonsson et al. 2015; Simon et al. 2009;
Uguz et al. 2017). Ionic pumps integrated with recoding
electrode arrays have also been demonstrated for both
in vitro and in vivo biointerfacing (Jonsson et al. 2016;
Proctor et al. 2018). A drawback for this approach is the
size limit of molecules that can be delivered through the
membrane and such probes still require microfluidics to
bring the drug close to the membrane.
A conceptual design of a multi-modal and closed-loop
neuroprosthetic system for treating addictive disorders
may comprise of a sensing arm to detect ERP and an ef-
fector arm to deploy neurotransmitter release, both tar-
geting the mPFC as this area plays a superior role in
craving and addictive behaviour (George and Koob 2010,
2013). In terms of probe technology we aim to fabricate
soft ECoG arrays that conform to the curvature of the
brain and incorporate a microfluidic channel for drug
delivery. This can initially be implemented in a rat
model of cue-induced reinstatement of alcohol seeking.
Our ECoG arrays will thereby monitor neurophysio-
logical parameter changes underlying the development
of craving and addiction during conditioning for alcohol
and modulate them afterwards with the aim of prevent-
ing relapse. Following our recent efforts to adapt 3D
printing technologies for the production of fibers with
electrical, optical and microfluidic functionality, we will
print soft and customised implants adapted to deliver
multi-modal brain interface in the rat cortex (Athanasia-
dis et al. 2019).
It should be noted that chemical and electrical sens-
ing/stimulation are just two examples from a rapidly
expanding toolbox of interfacing techniques. Implanted
probes delivering focal cooling or heating have been
demonstrated to decrease or respectively increase the
excitability of surrounding cortical structures (Chen
et al. 2015; Fujioka et al. 2010). Focused ultrasound can
be delivered non-invasively via wearable probes and has
been shown to modulate neural activity in basal ganglia
in mice (Zhou et al. 2019). Optogenetic stimulation
without penetrating optical probes has also been recently
made possible using nanoparticle mediated upconver-
sion of infrared light (Chen et al. 2018). Thus, it is likely
that future technologies for brain-machine interfaces will
either be non-invasive or will blend seamlessly with host
tissues of the nervous system.
Conclusions
The neurobiological and electrophysiological parameters
described here link addiction-related behavioural deficits
to particular brain regions and cognitive origins. These pa-
rameters may, in the future, provide a basis for a compre-
hensive diagnosis of addictive pathologies using neural
interfaces. Brain stimulation methods, like tDCS, have
already revealed some beneficial effects on ERP, though
further research needs to be done to find the optimal
treatment strategies. Multimodal neural interfaces may
allow for refinement of the therapy beyond what electrical
stimulation or systemic drug application can achieve in
isolation. They could further enable sensing and identifi-
cation of pathogenic features characteristic of individual
patients and situations and could therefore open doors to
the development of personalized, targeted therapies.
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